| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 1,245 | 1,105 | +12.6% |
| EBITDA | 222 | 117 | +90.1% |
| EBITDA margin | 17.8% | 10.6% | +7.3 pts |
| Profit before tax | 110 | 9.6 | +1,052.3% |
| Net profit | 55.0 | −13.8 | — |
| EPS | ₹7.49 | −₹1.88 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 4,069 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 175 | 175 | 145 | 175 | 476 | ||
| 568 | 568 | 552 | 543 | 596 | ||
| 4,462 | — | — | — | — | ||
| 4,498 | 4,358 | 4,073 | 3,807 | 4,517 | ||
| — | +7.0% | +7.0% | −15.7% | — | ||
| 510 | 405 | 360 | 136 | 1,115 | ||
| 11.3% | 9.3% | 8.9% | 3.6% | 24.7% | ||
| 94.5 | −9.3 | −31.9 | −241 | 839 | ||
| 66.4 | −2.4 | −65.1 | −237 | 410 | ||
| 1.5% | −0.1% | −1.6% | −6.2% | 9.1% | ||
| ₹9.03 | −₹0.33 | −₹8.87 | −₹32.25 | ₹55.78 | ||
| — | +96.3% | +72.5% | −157.8% | — | ||
| — | 430 | 462 | 171 | 1,126 | ||
| — | −259 | −325 | −231 | −683 | ||
| 171 | 171 | 137 | −60.0 | 443 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 4,068.9 | |
| - Cash, Equiv & ST Investments | 476.2 | 174.8 | 145.1 | 175.0 | 175.0 | |
| + Total Debt | 595.8 | 543.4 | 551.6 | 567.6 | 567.6 | |
| Enterprise Value | — | — | — | — | 4,461.6 | |
| Revenue | 4,516.5 | 3,806.6 | 4,072.9 | 4,358.1 | 4,497.9 | |
| Growth %, YoY | — | -15.7 | +7.0 | +7.0 | — | |
| EBITDA | 1,114.6 | 136.0 | 360.4 | 405.2 | 510.3 | |
| Margin % | 24.68 | 3.57 | 8.85 | 9.30 | 11.34 | |
| EBIT | 838.5 | -241.4 | -31.9 | -9.3 | 94.5 | |
| Net Income | 409.6 | -236.8 | -65.1 | -2.4 | 66.4 | |
| Margin % | 9.07 | -6.22 | -1.60 | -0.06 | 1.48 | |
| EPS, Adj (current shares) | 55.78 | -32.25 | -8.87 | -0.33 | 9.03 | |
| Growth %, YoY | — | -157.8 | +72.5 | +96.3 | — | |
| Cash from Operations | 1,126.1 | 171.2 | 462.1 | 429.7 | — | |
| Capital Expenditures | -683.1 | -231.3 | -325.5 | -258.5 | — | |
| Free Cash Flow | 443.0 | -60.0 | 136.7 | 171.2 | 171.2 | |
Prices at the previous close · figures from the company's filings with NSE
Gujarat Alkalies and Chemicals (NSE: GUJALKALI) had a market capitalisation of ₹4,069 crore at the previous close (₹554.05 a share), a PE ratio of 61.3 on the last four quarters' profit and a price-to-book ratio of 0.78. In FY26 its consolidated net loss was ₹2.4 crore on revenue of ₹4,358 crore; in Q1 FY27 (April–June 2026) it was ₹55 crore. Its debt-to-equity ratio was 0.11 on 31 March 2026. Promoters held 47.28% of the shares on 30 September 2026.
Gujarat Alkalies and Chemicals' PE ratio is 61.3 at the previous close (₹554.05 a share): a market capitalisation of ₹4,069 crore divided by consolidated net profit of ₹66.4 crore over the last four quarters (Q2 FY26 to Q1 FY27).
Gujarat Alkalies and Chemicals' price-to-book (PB) ratio is 0.78 at the previous close: a market capitalisation of ₹4,069 crore divided by shareholders' equity (book value) of ₹5,191 crore on 31 March 2026. That is a book value of ₹706.82 per share against a share price of ₹554.05.
Gujarat Alkalies and Chemicals' book value per share was ₹706.82 on 31 March 2026: shareholders' equity of ₹5,191 crore divided by the 7.34 crore shares in issue, down 8.4% from ₹772.00 a year earlier. The share price at the previous close was ₹554.05.
Gujarat Alkalies and Chemicals' market capitalisation was ₹4,069 crore at the previous close: 7.34 crore shares at ₹554.05 each.
No. Gujarat Alkalies and Chemicals had borrowings of ₹568 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.11. Its cash and current investments were ₹189 crore, so its net debt was ₹379 crore.
Gujarat Alkalies and Chemicals' debt-to-equity ratio was 0.11 on 31 March 2026: borrowings of ₹568 crore against total equity of ₹5,191 crore. A year earlier, on 31 March 2025, it was 0.10.
Gujarat Alkalies and Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹5,191 crore on 31 March 2026, down 8.4% from ₹5,670 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹4,069 crore at the previous close.
In FY26, Gujarat Alkalies and Chemicals' return on equity (ROE) was −0.0% and its return on capital employed (ROCE) was −0.1%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −1.1% and ROCE −0.4%.
Gujarat Alkalies and Chemicals' dividend yield is 3.19% at the previous close: dividends of ₹17.70 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹554.05. They were ₹17.70 on 18 September 2026.
Gujarat Alkalies and Chemicals' basic earnings per share (EPS) were −₹0.33 in FY26, against −₹8.87 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹9.04.
In FY26 (April 2025–March 2026), Gujarat Alkalies and Chemicals' consolidated net loss was ₹2.4 crore, narrower than the loss of ₹65.1 crore in FY25, on revenue from operations of ₹4,358 crore (up 7.0%).
Gujarat Alkalies and Chemicals will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, the date of the board meeting it has notified to the exchanges.
In 2026, Gujarat Alkalies and Chemicals has declared one dividend: ₹17.70 with record date 18 September 2026.
Promoters held 47.28% of Gujarat Alkalies and Chemicals on 30 September 2026, unchanged from the previous quarter and up 1.00 percentage points from 46.28% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Gujarat Alkalies and Chemicals generated ₹430 crore of cash from operations and spent ₹259 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹171 crore. In FY25 it was ₹137 crore.
On 30 September 2026, Gujarat Alkalies and Chemicals' shares were held by promoters 47.28%, foreign portfolio investors (FII/FPI) 3.26%, domestic institutions (DII) 2.70% (including mutual funds at 1.03%) and retail and other non-institutional investors 46.77%. Over the year, FII holding was up 2.24 percentage points from 1.02% and DII holding was down 1.83 percentage points from 4.53%.
On FY26 consolidated figures, against Yasho Industries and Epigral: Gujarat Alkalies and Chemicals' operating margin of −0.2% is the lowest of the three (Yasho Industries 10.7%, Epigral 15.8%; peer average 13.2%); its return on equity of −0.0% is the lowest of the three (Yasho Industries 5.9%, Epigral 16.1%; peer average 11.0%).
In FY26, Gujarat Alkalies and Chemicals earned net profit of ₹2.4 crore on revenue of ₹4,358 crore, against ₹25.3 crore on ₹830 crore for Yasho Industries. Gujarat Alkalies and Chemicals' operating margin was −0.2% (Yasho Industries 10.7%) and its return on equity −0.0% (Yasho Industries 5.9%).
Gujarat Alkalies and Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 23 July 2026: consolidated net profit ₹55 crore, against a loss of ₹13.8 crore in Q1 FY26; revenue from operations ₹1,245 crore, up 12.6% year on year.
From Gujarat Alkalies and Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.